Global Medical Genetics
Author Instructions
Thank you for contributing to Global Medical Genetics. Please read the instructions carefully and observe all the directions given. Failure to do so may result in unnecessary delays in publishing your article.
| APC Type | 2023 Article Processing Charge (APC) |
| Regular | None |
| (Society Funded by: International Knowledge Direct Medical Association) |
Papers would be processed via Online Platform: https://www.editorialmanager.com/gmg
Please submit only digital files on the submission system
- All authors: full name, department, affiliation
- Corresponding author: full name, degrees, department, affiliation, mailing address, telephone and fax number, e-mail address
- Must be digital - hard copy submissions are not accepted
- See the section Article Types for word limit
- Cited sequentially in AMA style
- Cited sequentially in the main document, must be saved separately from the main
document
- Must be saved separately from the main document
- Required if you plan to reproduce content from a published source or include a photograph of a patient
- Patient permission forms available at www.thieme.com/journal-authors
The following graph shows what types of articles are accepted for publication, and what requirement they may have.
| Article Type | Abstract Limit | Keywords Limit | Title Limit |
| Original Article | 300 words | 3 to 5 key words | No Limit |
| Review | 300 words | 3 to 5 key words | No Limit |
| Short Communication | 120 words | 3 key words | No Limit |
· You must submit a digital copy of your manuscript. Hard copy submissions are not accepted.
· Keep the format of your manuscript simple and clear. We will set your manuscript according to our style—do not try to “design” the document.
· The manuscript, including the title page, abstract and keywords, text, references, figure captions, and tables should be typewritten, double-spaced in 12-point font with 1-inch margins all around and saved as one file.
· Indicate the type of manuscript in the title, choosing from Original article, Review, or Short Communication
· Title page, Abstract, Main Text, Figure Legend, and References should be saved on a separate file.
· Each figure should be saved as its own separate file. Do not embed figures within the manuscript file. This requires special handling by Thieme’s Production Department.
· Keep abbreviations to a minimum and be sure to explain all of them the first time they are used in the text.
· The manuscripts should be written in consistent British or American English.
· The authors should use Système International (SI) measurements. For clarity, nonmetric equivalents may be included in parentheses following the SI measurements.
· Use generic names for drugs. You may cite proprietary names in parentheses along with the name and location of the manufacturer.
· Credit suppliers and manufacturers of equipment, drugs, and other brand-name material mentioned in the manuscript within parentheses, giving the company name and primary location.
· This journal adheres to a single-blinded peer-review policy. The title page should be included in the main document.
· The title page should list the article title and the corresponding author’s full name, degree, title, department, affiliation, mailing address, e-mail address, and telephone and fax numbers. It should also list the full name, department, and affiliation of every co-author.
· Any change of affiliation requests will not be allowed after publication. A note about the author's new address can be added to the article's webpage if needed.
· If the article has been submitted on behalf of a consortium, all author names and affiliations should be listed at the end of the manuscript.
· Authors are required to disclose all financial and personal relationships that might influence their work, and all authors should disclose possible conflicts of interest, in their title page.
· The abstract should be prepared on a separate page, and must not exceed 300 words in length. (As for Short communication must not exceed 120 words in length)
· 3-5 keywords should be supplied. (As for Short communications, 3 key words should be supplied).
· The purpose of the investigation should be stated, followed by a description of the study design or experimental procedure, main findings or major contributions, and finally the specific conclusion or recommendations.
· Sufficient information should be included for the abstract to be easily understood without reference to the text, and any new and important aspects of the study should be emphasized.
· Text is to be divided into sections with the following headings consecutively in principle: Introduction, Material and Methods, Results, Discussion, Conclusion and Acknowledgement (if needed).
· Papers including human or animal subjects must include a statement of approval by appropriate agencies in the text.
· Use generic names of drugs or devices. If a particular brand was used in a study, insert the brand name along with the name and location of the manufacturer in parentheses after the generic name when the drug or device is first mentioned in the text.
· Quantities and units should be expressed in accordance with the recommendations of the International System of Units (SI), 8th edition 2006 (www.bipm.orgutilscommonpdfsi_brochure_8_en.pdf).
· When abbreviations are used, give the full term followed by the abbreviation in parentheses the first time it is mentioned in the text, such as inferior gleno-humeral ligament (IGHL).
· Please clearly distinguish the hierarchy of headings within the manuscript by using capital letters, underline, italic, and bold styles as necessary.
· As needed, use italic, superscripts, subscripts, and boldface, but otherwise do not use multiple fonts and font sizes.
· Do not insert page or section breaks except where noted in the Author Instructions.
· Use hard returns (the Enter key) only at the end of a paragraph, not at the end of a line. Allow lines of text to break automatically in your word-processing software. Do not justify your text.
· Use only one space, not two, after periods.
· Create tables using the Table function in Microsoft Word.
Thieme offers a language editing service for manuscripts, abstracts and theses in partnership with Enago, a world-leading provider of author services to researchers around the world. Authors can choose from a range of editing services and get their manuscripts edited by Enago’s professional medical editors. Authors that wish to use this service will receive a 20% discount on all editing services. To find out more information or get a quote, please visit https://www.enago.com/thieme
The source of any financial support received and recognition of personal assistance for the work being published should be indicated at the end of the article, just before the Reference section, under the heading Acknowledgments.
All authors (including corresponding and co-authors associated with the manuscript) must make a formal statement at the time of submission indicating any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication. Such conflicts might include, but are not limited to, shareholding in or receipt of a grant or consultancy fee from a company whose product features in the submitted manuscript or which manufactures a competing product. Should the article be accepted for publication, this information will be published with the paper.
Types of conflicts include: Consulting, Royalties, Research Support, Institutional Support, Ownership, Stock/Options, Speakers Bureau, and Fellowship Support. Any commercial entity whose products are described, reviewed, evaluated, or compared in the manuscript, except for those disclosed in the Acknowledgments section, are potential conflicts.
This journal follows the guidelines of the International Committee of Medical Journal Editors and an ICMJE disclosure of potential conflicts of interest (COI) form must be submitted for each author at the time of manuscript submission. Forms must be submitted even if there is no conflict of interest. It is the responsibility of the corresponding author to ensure that all authors adhere to this policy prior to submission.
A conflict of interest statement must also be included in the manuscript after any "Acknowledgements" and "Funding" sections and should summarize all aspects of any conflicts of interest included on the ICMJE form. If there is no conflict of interest, authors must include 'Conflict of Interest: none declared'.
Please click http://www.icmje.org/conflicts-of-interest to download a Conflict of Interest form. The disclosure information is important in article processing. If the provided forms are incomplete or missing, it can cause delays in publishing of article.
References should be the most recent and pertinent literature available. It is essential that they are complete and thoroughly checked. If the reference information is incomplete, good online sites to search for full details are the National Library of Medicine: www.nlm.nih.gov; Books in Print: www.booksinprint.com; PubMed: www.ncbi.nlm.nih.gov/PubMed/; or individual publisher Web sites.
· References must be listed in AMA style, using Index Medicus journal title abbreviations.
· References follow the article text. Insert a page break between the end of text and the start of references.
· References must be cited sequentially (NOT alphabetically) in the text using superscript numbers.
· By way of exception to AMA style, do not italicize book titles or journal title abbreviations and do not put a period at the end of a reference.
· List all author names, up to and including six names. For more than six authors, list the first three followed by et al.
· References should be styled per the following examples:
1. Citing a journal article:
Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma-globulin. N Engl J Med 1986;315:341–347
2. Citing a chapter in a book:
Toma H. Takayasu’s arteritis. In: Novick A, Scoble J, Hamilton G, eds. Renal Vascular Disease. Philadelphia: WB Saunders; 1995:47–62
3. Citing a book:
Stryer L. Biochemistry. 2nd ed. San Francisco: WH Freeman; 1981:559–596
4. Citing a thesis:
Stern I. Hemorrhagic Complications of Anticoagulant Therapy [Ph.D. dissertation]. Evanston, IL: Northwestern University; 1994
5. Citing a government publication:
Food and Drug Administration. Jin Bu Huan Herbal Tablets. Rockville, MD: National Press Office; April 15, 1994. Talk Paper T94-22
6. Citing an online article:
Rosenthal S, Chen R, Hadler S. The safety of acelluler pertussis vaccine vs whole-cell pertussis vaccine [abstract]. Arch Pediatr Adolesc Med [serial online]. 1996;150:457–460. Available at: http://www.ama-assn.org/sci-pubs/journals/archive/ajdc/vol_150/no_5/abstract/htm. Accessed November 10, 1996
7. Citing a symposium article:
Eisenberg J. Market forces and physician workforce reform: why they may not work. Paper presented at: Annual Meeting of the Association of American Medical Colleges; October 28, 1995; Washington, DC
· Figures include photographs, drawings, graphs, bar charts, flow charts, and pathways, but NOT lists or tables.
· Figueres prepared by the author(s) will be used in the online version of the journal. Cite each figure in the text and mark in the right margin of the page.
· Figures must be cited sequentially in the text. Number all figures (and corresponding figure captions) sequentially in the order they are cited in the text.
· Figure captions should be written after the reference list. Insert a page break between the end of references and the start of figure captions.
· Figure captions should include a description of the figure and/or each lettered part (A, B, etc.) and of any portions of the figure highlighted by arrows, arrowheads, asterisks, etc.
· For a figure borrowed or adapted from another publication (used with permission), add a credit line in parentheses at the end of each figure legend. This credit line should be a complete bibliographic listing of the source publication (as a reference), or other credit line as supplied by the copyright holder. For example (Reprinted with permission from Calfee DR, Wispelwey B. Brain abscess. Semin Neurol 2000;20:357.)
· If a figure has already been published, it is the author’s responsibility to obtain written permission to reproduce or modify from the copyright holder, and acknowledge the original source in the legend
· Short Communication should be composed of 2 sheets or less of figures.
· Data given in tables should be commented on but not repeated in the text. Be sure that lists or columns of related data are composed in a word-processing program like the rest of the text.
· Do not intersperse tables in the text. Tables should appear after the figure captions. Insert a page break between the end of the figure captions and the start of the tables.
· Tables must be double-spaced and numbered in the same sequence they are cited in the text. A short descriptive title should be provided for each table.
· If a table contains artwork, supply the artwork separately as a digital file.
· For tables borrowed or adapted from another publication (used with permission), add a credit line as the first footnote beneath each table. This credit line should be a complete bibliographical listing of the source publication (as a reference), or other credit line as supplied by the copyright holder. For example, “Reprinted with permission from Calfee DR, Wispelwey B. Brain abscess. Semin Neurol 2000;20:357.” (“Data from . . .” or “Adapted from . . .” may also be used, as appropriate.)
· Other footnotes for tables should be indicated in the table using superscript letters in alphabetical order.
· Any abbreviations used in the table should be explained at the end of the table in a footnote.
· We encourage authors to submit detailed supplementary, including dataset, document, image, video, software code, protocol, supporting information, table etc, but some large datasets (>100 MB) should be deposited in specialized service providers by author.
· It is best to use Adobe Photoshop to create and save images, and Adobe Illustrator for line art and labels.
· Do not submit art created in Microsoft Excel, Word, or PowerPoint. These files cannot be used by the typesetter.
· Save each figure in a separate file.
· Do not compress files.
· All black-and-white and color artwork should be at a resolution of 300 dpi (dots per inch) in TIFF format. Line art should be 1,200 dpi in EPS or TIFF format. Contact the Production Editor at Thieme if you are unsure of the final size.
· It is preferable for figures to be cropped to their final size (approximately 3? inches for a single column and up to 7 inches for a double column), or larger, and in the correct orientation. If art is submitted smaller and then has to be enlarged, its resolution (dpi) and clarity will decrease.
Note: Lower resolutions (less than 300 dpi) and JPEG format (.jpg extension) for grayscale and color artwork are strongly discouraged due to the poor quality they yield in printing, which requires 300 dpi resolution for sharp, clear, detailed images. JPEG format, by definition, is a lower resolution (compressed) format designed for quick upload on computer screens.
· Black-and-white artwork can be halftone (or grayscale) photographs, radiographs, drawings, line art, graphs, and flowcharts. Thieme will only accept digital artwork.
· If possible, do not send color art for conversion to black-and-white. Do the conversion yourself so that you can check the results and confirm in advance that no critical details are lost or obscured by the change to black-and-white.
· For best results, line art should be black on a white background. Lines and type should be clean and evenly dark. Avoid screens or cross-hatching, as they can darken or be uneven in printing and lead to unacceptable printing quality.
· All color artwork should be saved in CMYK, not RGB.
· Arrows, asterisks, and arrowheads (or other markers) should be white in dark or black areas and black in light or white areas, and large in size. If not, these highlighting marks may become difficult to see when figures are reduced in size during the typesetting process.
· Use 1-point (or thicker) rules and leader lines.
· Capitalize the first word of each label and all proper nouns. Consider using all capitals if you need a higher level of labels.
· Where there are alternate terms or spellings for a named structure, use the most common one and make sure it is consistent with what is used in the text.
· Avoid using multiple fonts and font sizes for the labels; use only one or two sizes of a serif font.
The Article Publication Charge (APC) is waived for accepted manuscripts from 2020 - 2021.
· Consult the checklist on the first page of this document to ensure that you are ready to submit your manuscript.
· Please note: There are no submission charges to submit your manuscript to this journal.
Global Medical Genetics encourages the submission of manuscripts that have been deposited in an initial draft version in preprint repositories such as Research Square, arXiv, and medRxiv. Drafts of short conference abstracts or degree theses posted on the website of the degree-granting institution, and draft manuscripts deposited on authors’ or institutional websites are also welcome. All other prior publication is forbidden.
During submission, authors should (1) note use of the preprint repository in the cover letter, (2) state what adjustments and/or updates the draft has undergone between deposition and submission and (3) cite the preprint, including the DOI, as a reference in the manuscript.
After submission to the journal, and until a final decision has been made, authors are discouraged from depositing versions of their manuscript as preprints. Upon publication authors should add a link from the preprint to the published article. Twelve months after publication, authors can update the preprint with the accepted manuscript.
· Should the editors decide that your article requires a revision, you will need to make the changes via a word-processing program and resubmit it electronically.
· The best way to make revisions to your manuscript is by enabling the Track Changes mode in Microsoft Word, which will automatically highlight and mark up revised text. Please submit both a marked up copy and a clean copy of your revised manuscript to the submission system.
Page proofs will be sent to you via email. The proofs will be in a PDF file format, which should be opened using Acrobat Reader software. You will receive further instructions with your proofs. Take this opportunity to check the typeset text for typographic and related errors. Elective alterations are difficult to accommodate owing to the associated time and expense of introducing them. Therefore, please be sure that when you submit your manuscript, it is accurate, complete, and final.The corresponding author will be given an opportunity to proofread the gallery of an accepted manuscript. Major changes are not permitted at this time.
The legislation on product liability makes increased demands on the duty of care to be exercised by authors of scientific research and medical publications. This applies in particular to papers and publications containing therapeutic directions or instructions and doses or dosage schedules. We therefore request you to examine with particular care, also in your own interest, the factual correctness of the contents of your manuscript once it has been copyedited and returned to you in the form of galley proofs. The responsibility for the correctness of data and statements made in the manuscript rests entirely with the author.
Each author should have made the following contributions towards the completion of the manuscript:
1. Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data
2. Drafting the article or revising it critically for important intellectual content
3. Final approval of the version to be published
Submitted manuscripts must represent original research not previously published nor being considered for publication elsewhere. The editors and Thieme combat plagiarism, double publication, and scientific misconduct with the software CrossCheck powered by iThenticate. Your manuscript may be subject to an investigation and retraction if plagiarism is suspected.
If you plan to reproduce text, tables, or figures from a published source, you must first obtain written permission from the copyright holder (usually the publisher). This is required even if the material is from your own published work. For material never before published and given to you by another person, you must obtain permission from that person. Serious delays to publication can be incurred if permissions are not obtained.
As the author, it is your responsibility to obtain all permissions, pay any permission fees, furnish copies of permissions to Thieme with your manuscript, and include a credit line at the end of the figure caption, beneath the table, or in a text footnote.
Articles are published under the “CC-BY 4.0” license. This means that everyone is free to copy, distribute and transmit the published article. The full text of the license can be found at https://creativecommons.org/licenses/by/4.0
The Journal supports trial registration. All trials reported must be registered at an official registry recognized by the International Committee of Medical Journal Editors, such as ClinicalTrials.gov ( www.clinicaltrials.gov) or any of the primary registries on the World Health Organization‘s International Clinical Trial Registry Platform (www.who.int/ictrp).
The journal is very concerned about ethical standards. Please provide proof that the terms of the latest version of the “World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects” have been adhered to or provide approval of your local ethics committee. The same applies to animals. Please provide proof that experiments involving animals were carried out in compliance with the “Guide for the Care and Use of Laboratory animals” published by the National Academy of Sciences or else provide approval of your local ethics committee.
You must obtain a signed patient permission form for every patient whose recognizable photograph will be used. If you do not supply this, the identity of the patient must be obscured before the image is published; this could interfere with the instructive value of the photograph.
The personal rights of people who are recognizable on images must be protected. Please provide a written consent form for publication signed by every recognizable person. For persons under 18 years of age / persons supervised, please provide the signature of both parents / the legal guardian / supervisor. A suitable declaration of consent form can be obtained in our authors' lounge. Patient permission forms are available at www.thieme.com/journal-authors
We cannot accept or store illustrations in which personal data of third parties are included. Please submit images in completely anonymous form, free of personal data only! Such data may not only be directly visible in the image (e.g., a patient name or a date of birth in an X-ray image); they can also be included in the metadata of the image, which is accessible with the appropriate software. They may also be obscured by a cropping feature (such as PowerPoint or Word), but can be made visible underneath. If you have questions about data protection regulations, please contact us before submitting your manuscript.
Please contact the Editors or Thieme Publishers with any questions.
Lihong Ye
State Key Laboratory of Medicinal Chemical Biology
College of Life Sciences Nankai University
Tianjin, China.
Email: jeo@escience.cn
Lei Zang State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Laboratory of Blood Disease Gene Therapy, Tianjin, China zhanglei1@ihcams.ac.cn
Kevin Liu
Managing Editor
Email: liuqian@tmu.edu.cn
gmg@thieme.com
Sharon Huang
Thieme Publishers No.A021, 2/F Beijing Silver Tower,
No.2 East 3rd Ring North Road, ChaoYang District,
Beijing 100027 P.R. China
Email: sharon.huang@thieme.com
Sudeshna Roy
Thieme Medical and Scientific Publishers Private Limited
A-12, Second Floor, Sector -2,
NOIDA -201301
Uttar Pradesh, India
Email: Sudeshna.Roy@thieme.in
Last Updated: February 2023